Evidence map›Paper›PMID 28342911›Full record

Trial reportThe Journal of allergy and clinical immunology2017

Basophils, high-affinity IgE receptors, and CCL2 in human anaphylaxis.

Peter Korosec, Paul J Turner, Mira Silar, Peter Kopac, Mitja Kosnik, Bernhard F Gibbs, Mohamed H Shamji, Adnan Custovic, Matija Rijavec

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The Journal of allergy and clinical immunology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 80 citations in OpenAlex.

  1. Trial
  2. Vespula spp. venom immunotherapy: basophil excitability and FcAllergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2026
    Article
  3. Review
  4. Review
  5. IgE levels correlate with FcFrontiers in allergy · 2026
    Article
  6. Review
  7. Review
  8. Type 2 immunity in allergic diseases.Cellular & molecular immunology · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Bronchial Asthma and COVID-19: Etiology, Pathological Triggers, and Therapeutic Considerations.Pathophysiology : the official journal of the International Society for Pathophysiology · 2024
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Peter KorosecUniversity Hospital of Respiratory and Allergic Diseases, Golnik, Slovenia. Electronic address: peter.korosec@klinika-golnik.si.
Paul J TurnerSection of Paediatrics and MRC and Asthma UK Centre in Allergic Mechanisms of Asthma, Imperial College London, London, United Kingdom.
Mira SilarUniversity Hospital of Respiratory and Allergic Diseases, Golnik, Slovenia.
Peter KopacUniversity Hospital of Respiratory and Allergic Diseases, Golnik, Slovenia.
Mitja KosnikUniversity Hospital of Respiratory and Allergic Diseases, Golnik, Slovenia.
Bernhard F GibbsMedway School of Pharmacy, University of Kent, Chatham, United Kingdom.
Mohamed H ShamjiSection of Allergy and Clinical Immunology, National Heart and Lung Institute and MRC and Asthma UK Centre in Allergic Mechanisms of Asthma, Imperial College London, London, United Kingdom.
Adnan CustovicSection of Paediatrics and MRC and Asthma UK Centre in Allergic Mechanisms of Asthma, Imperial College London, London, United Kingdom.
Matija RijavecUniversity Hospital of Respiratory and Allergic Diseases, Golnik, Slovenia.
University Clinic of Pulmonary and Allergic Diseases Golnik · SIImperial College London · GBAsthma UK · GBMedway School of Pharmacy · GB

Funding

Medical Research Council G1000758Medical Research Council MR/K010468/1
6 · The paper itself

Abstract

backgroundThe role of basophils in anaphylaxis is unclear.

objectiveWe sought to investigate whether basophils have an important role in human anaphylaxis.

methodsIn an emergency department study we recruited 31 patients with acute anaphylaxis, predominantly to Hymenoptera venom. We measured expression of basophil activation markers (CD63 and CD203c); the absolute number of circulating basophils; whole-blood FCER1A, carboxypeptidase A3 (CPA3), and L-histidine decarboxylase (HDC) gene expression; and serum markers (CCL2, CCL5, CCL11, IL-3, and thymic stromal lymphopoietin) at 3 time points (ie, during the anaphylactic episode and in convalescent samples 7 and 30 days later). We recruited 134 patients with Hymenoptera allergy and 76 healthy control subjects for comparison. We then investigated whether the changes observed during venom-related anaphylaxis also occur during allergic reactions to food in 22 patients with peanut allergy undergoing double-blind, placebo-controlled food challenge to peanut.

resultsThe number of circulating basophils was significantly lower during anaphylaxis (median, 3.5 cells/μL) than 7 and 30 days later (17.5 and 24.7 cells/μL, P < .0001) and compared with those in patients with venom allergy and healthy control subjects (21 and 23.4 cells/μL, P < .0001). FCER1A expression during anaphylaxis was also significantly lower than in convalescent samples (P ≤ .002) and control subjects with venom allergy (P < .0001). CCL2 levels (but not those of other serum markers) were significantly higher during anaphylaxis (median, 658 pg/mL) than in convalescent samples (314 and 311 pg/mL at 7 and 30 days, P < .001). Peanut-induced allergic reactions resulted in a significant decrease in circulating basophil counts compared with those in prechallenge samples (P = .016), a decrease in FCER1A expression (P = .007), and an increase in CCL2 levels (P = .003).

conclusionsOur findings imply an important and specific role for basophils in the pathophysiology of human anaphylaxis.

Indexed as

AdolescentAdultAgedAnaphylaxisAnimalsBasophilsCytokinesDouble-Blind MethodFemaleGene ExpressionHumansHymenopteraLeukocyte CountMaleMiddle AgedPeanut HypersensitivityCytokinesReceptors, IgEVenomsAnaphylaxisbasophilsCCL2CD63 activationFcεRI expressionserum tryptase

Identifiers

PMID28342911
PMCPMC5587023
OpenAlexW2601065165

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.